SE9603463D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- SE9603463D0 SE9603463D0 SE9603463A SE9603463A SE9603463D0 SE 9603463 D0 SE9603463 D0 SE 9603463D0 SE 9603463 A SE9603463 A SE 9603463A SE 9603463 A SE9603463 A SE 9603463A SE 9603463 D0 SE9603463 D0 SE 9603463D0
- Authority
- SE
- Sweden
- Prior art keywords
- new compounds
- absorbable
- methionine
- cysteine
- peptides
- Prior art date
Links
Abstract
A physiologically active peptide of formula (I): A-R1-R2-R3-R4-B wherein each variable has the meaning defined in the description at least one of R1, R2 and R3 being methionine and at most one of R1, R2 and R3 being cysteine, the entire peptide sequence containing 3 to 30 amino acid residues. These peptides are absorbable by the epithelial cell lining in a mammal resulting in a modulated immune response and thereby a therapeutic effect against disease.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9603463A SE9603463D0 (en) | 1996-09-23 | 1996-09-23 | New compounds |
AU44770/97A AU4477097A (en) | 1996-09-23 | 1997-09-15 | Methionine containing peptides having immunomodulatory effect |
PCT/SE1997/001550 WO1998012216A1 (en) | 1996-09-23 | 1997-09-15 | Methionine containing peptides having immunomodulatory effect |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9603463A SE9603463D0 (en) | 1996-09-23 | 1996-09-23 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9603463D0 true SE9603463D0 (en) | 1996-09-23 |
Family
ID=20403985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9603463A SE9603463D0 (en) | 1996-09-23 | 1996-09-23 | New compounds |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4477097A (en) |
SE (1) | SE9603463D0 (en) |
WO (1) | WO1998012216A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU9655698A (en) * | 1997-10-10 | 1999-05-03 | Astra Aktiebolag | Synthetic genes with immunomodulatory effects |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5494672A (en) * | 1989-04-28 | 1996-02-27 | S.P.I. Synthetic Peptides Incorporated | Pseudomonas peptide composition and method |
WO1993024136A1 (en) * | 1991-01-17 | 1993-12-09 | Terman David S | Tumor killing effects of enterotoxins, superantigens, and related compounds |
EP0629213B1 (en) * | 1992-03-07 | 1996-10-23 | Morinaga Milk Industry Co., Ltd. | Use of an immunostimulatory agent |
US6696061B1 (en) * | 1992-08-11 | 2004-02-24 | President And Fellows Of Harvard College | Immunomodulatory peptides |
AUPM446594A0 (en) * | 1994-03-16 | 1994-04-14 | Csl Limited | Cytotoxic t-cell epitopes identified within epstein-barr virus |
CA2187336A1 (en) * | 1994-04-08 | 1995-10-19 | Henry M. Franzen | Pharmaceutical formulations for treating japanese cedar pollen allergy |
AP690A (en) * | 1994-07-05 | 1998-10-16 | Steeno Res Group A/S | Immunomodulators based on a polypeptide other than human interleukin 10. |
SE9403526D0 (en) * | 1994-10-14 | 1994-10-14 | Astra Ab | New Peptides |
EP0923604A1 (en) * | 1996-04-12 | 1999-06-23 | Astra Aktiebolag | Cysteine-containing or methioine-containing peptides with immunomodulatory effects |
-
1996
- 1996-09-23 SE SE9603463A patent/SE9603463D0/en unknown
-
1997
- 1997-09-15 WO PCT/SE1997/001550 patent/WO1998012216A1/en active Application Filing
- 1997-09-15 AU AU44770/97A patent/AU4477097A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1998012216A1 (en) | 1998-03-26 |
AU4477097A (en) | 1998-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2016950T3 (en) | Pharmaceutical composition comprising an exendin-4 peptide | |
DE69435105D1 (en) | Derivatives of therapeutic peptides | |
DK0719340T3 (en) | Cloned glutamic acid decarboxylase | |
EP2327712A3 (en) | Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides | |
DE69126568D1 (en) | New physiologically active pig peptide (CNP-53) | |
RU94041224A (en) | PEPTIDES WITH ORGAN-PROTECTIVE ACTIVITY, PHARMACEUTICAL COMPOSITION ON THEIR BASIS AND THEIR USE IN THERAPY | |
SE9403526D0 (en) | New Peptides | |
TR200103339T2 (en) | New LHRH-antagonists with improved solubility features. | |
DE69617396D1 (en) | Peptides affecting T cells | |
SE9603468D0 (en) | New compounds | |
SE9501067D0 (en) | New peptides | |
DE68917837D1 (en) | Peptide compounds. | |
KR960702754A (en) | VAGINAL PREPARATION CONTAINING PHYSIOLOGICALLY ACTIVE PEPTIDE containing physiologically active peptides | |
DE69409237T2 (en) | ORAL, PHARMACEUTICAL COMPOSITIONS CONTAINING A PROTEIN OR PEPTIDE, AN ANTIBODY AND POLYMER BALLS | |
DK1154786T3 (en) | Compositions for modulating mucus secretion | |
SE9603463D0 (en) | New compounds | |
SE9603461D0 (en) | New compounds | |
SE9603466D0 (en) | New compounds | |
SE9603462D0 (en) | New compounds | |
ATE371737T1 (en) | PROTEAS RESISTANT FLINT ANALOGUE | |
TR200200599T2 (en) | Human insulin monomeric analogues. | |
DE69837145D1 (en) | SELECTION MARKER | |
ATE69240T1 (en) | MITOGENIC PEPTIDES. | |
MX9605651A (en) | New peptides with immunomodulatory effects. | |
ECSP972139A (en) | INTERFERON CONJUGATES (CASE RAN 410077) |